How Parimer and Luna Labs are Advancing Post-Operative Care Through Strategic Partnership

Luna Labs is a product development company working with leading organizations and key government agencies to create unique solutions for complex challenges in defense, industrial, and healthcare markets.
With small business agility and large business capabilities, Luna Labs accelerates breakthrough solutions from concept to early-stage growth.
Developing a Sprayable Hydrogel for Post-Operative Care
Luna Labs’ biotech team developed an innovative barrier film derived from chitosan, engineered specifically to prevent post-surgical adhesions. While the initial flat-sheet format demonstrated strong potential in early applications, clinical feedback from surgeons highlighted an opportunity to enhance the technology's versatility. Specifically, surgeons noted that
conforming flat sheets to complex anatomical surfaces presented practical limitations during procedures.
Responding to this clinical insight, the team advanced their research to develop a sprayable hydrogel formulation. This next-generation approach showed exceptional promise in preclinical studies. To optimize the path toward FDA approval and commercialization, Luna Labs sought to
complement their strong research foundation with additional expertise in regulatory strategy and scaled production capabilities.
This strategic outlook led to their exploration of partnership opportunities and their introduction to Parimer Scientific.
How Parimer and Luna Labs Worked Together
Finding Creative Solutions
Parimer worked closely with Luna Labs to modify their processes and ensure regulatory compliance while maintaining the product’s integrity. Key challenges included:
-
ï‚· Maintaining molecular weight while making the product water-soluble.
​​
-
Overcoming sterilization hurdles without degrading the molecular structure.
Challenges in Manufacturing and Scaling
Produce the product under GMP-compliant processes to support testing in a swine model to refine dosing and usability.
Gather critical data to support biosafety and efficacy testing for FDA’s Investigational Device Exemption (IDE) and Premarket Approval (PMA) processes.
Promising Partnership
Luna Labs’ partnership with Parimer exemplifies the impact of collaboration in advancing innovative solutions. By combining Luna Labs’ visionary R&D with Parimer’s expertise in scalable manufacturing and regulatory compliance, the sprayable hydrogel product is on its way to success.

Looking Ahead
Luna Labs plans to manufacture the hydrogel to support clinical testing and is exploring the addition of drugs to enhance performance.
The company anticipates continued future funding for this technology and expects to continue this partnership into the future. Parimer is a trusted Luna Labs’ partner, reinforcing their commitment to innovation and excellence in healthcare solutions.